- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 17.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 17.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.85M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $500K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $476K |
| Capex | Q1 2026 · Mar 31, 2026 | $2.48M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.11M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.85M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $2.61M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $87.58M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $93.89M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $71.37M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $78.54M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $94.54M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $99.59M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $178.59M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $178.85M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $261.46M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $261.15M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.29 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.26 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $43.54M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $40.58M |
| Net Income | Q1 2026 · Mar 31, 2026 | $5.12M |
| Net Income | Q1 2026 · Mar 31, 2025 | $4.75M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $9.55M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $6.17M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $89.98M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $81.6M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $32.92M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $31.65M |
| Revenue | Q1 2026 · Mar 31, 2026 | $122.89M |
| Revenue | Q1 2026 · Mar 31, 2025 | $113.25M |